Russell Skibsted - 16 Jul 2024 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Financial Officer
Signature
/s/ Russell Skibsted by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
16 Jul 2024
Net transactions value
$0
Form type
4
Filing time
18 Jul 2024, 16:46:04 UTC
Previous filing
28 Nov 2023
Next filing
18 Sep 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Units Award $0 +28,000 $0.000000 28,000 16 Jul 2024 Common Stock 28,000 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting of 50% on 7/16/25 and the remainder upon achievement of certain criteria.